Get started
Author

J Andrew Andrew Livingston

Observed names: J. Andrew Andrew Livingston, J. Andrew Livingston, J. Andrew. Livingston, John Andrew Livingston
ORCID: 0000-0002-1337-3282
Observed ORCID: 0000-0002-1337-3282
OpenAlex ID: A5083143523
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
2021 · Daniel J. Klionsky, Amal Kamal Abdel-Aziz, et al. · Autophagy · 2,608
PDF
A phase II multi-arm study to test the efficacy of oleclumab and durvalumab in specific sarcoma subtypes.
2022 · Neeta Somaiah, J Andrew Andrew Livingston, et al. · Journal of Clinical Oncology · 8
Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review
2023 · Kelsey L. Corrigan, Bryce B. Reeve, et al. · Supportive Care in Cancer · 6
PDF
A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.
2022 · Viswatej Avutu, Emily K Slotkin, et al. · Journal of Clinical Oncology · 3
Development of a Multidisciplinary Adolescent and Young Adult Program at a Large Academic Cancer Center
2026 · Michael E. Roth, Wendy Griffith, et al. · JCO Oncology Practice · 2
Phase II trial of olaparib and ceralasertib in patients with recurrent osteosarcoma: Lung-only resectable cohort efficacy and correlative biomarker results.
2026 · Suzanne J. Forrest, Amanda Marinoff, et al. · Journal of Clinical Oncology · 1
Spatial RNA–protein profiling of antibody–drug conjugate (ADC) targets in leiomyosarcoma (LMS).
2026 · Carlos Torrado, J. Andrew Livingston, et al. · Journal of Clinical Oncology · 1
Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study
2026 · Efstratios Koutroumpakis, Efthymios Triantafyllou, et al. · ESC Heart Failure · 1
Differences in time to treatment and impact on overall survival in adolescents and young adults with Hodgkin lymphoma
2025 · Carlos A. Cruz, Elizabeth R. Rodriguez, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Satisfaction with and recommendations to improve telehealth visits among adolescents and young adults with cancer during the COVID-19 pandemic.
2021 · Maria Chang Swartz, Michael Roth, et al. · Journal of Clinical Oncology · 1
Genetic Markers of Early Skeletal Muscle Loss in Adolescent and Young Adult Cancer Patients Treated with Anthracyclines
2026 · Savannah V. Rauschendorfer, Amanda Brandt, et al. · Journal of Adolescent and Young Adult Oncology
Abstract B024: Immune checkpoint blockade (ICB) in advanced/metastatic leiomyosarcoma (LMS): Real-world cohort from MD Anderson
2026 · Nassar El Assaad, Michel S. Nakazawa, et al. · Cancer Research
Myoepithelial carcinoma: Defining natural history and therapeutic outcomes in a rare malignancy.
2026 · Madison Ginn, Davis Ingram, et al. · Journal of Clinical Oncology
SATURN-STS: Phase II study of neoadjuvant atezolizumab with doxorubicin, concurrent atezolizumab with pre-operative radiation therapy and adjuvant atezolizumab in patients with high-risk surgically resectable extremity and truncal soft tissue sarcoma.
2026 · Ahsan Saleem Farooqi, Neeta Somaiah, et al. · Journal of Clinical Oncology
Real-world outcomes of doxorubicin plus trabectedin (D+T) in leiomyosarcoma (LMS).
2026 · Stephanie Soewito, Nassar El Assaad, et al. · Journal of Clinical Oncology
From eligibility to enrollment: Evaluating barriers to clinical trial participation for leiomyosarcoma (LMS) at MD Anderson Cancer Center (MDACC).
2026 · Nisha Bhatti, Ravin Ratan, et al. · Journal of Clinical Oncology
Immune checkpoint blockade (ICB) in advanced/metastatic leiomyosarcoma (LMS): Real-world cohort from MD Anderson.
2026 · Nassar El Assaad, Michael S. Nakazawa, et al. · Journal of Clinical Oncology
PDF
Outcomes of malignant melanotic nerve sheath tumors (MMNST): A retrospective cohort study.
2026 · Cissimol Joseph, Reshma Vilson, et al. · Journal of Clinical Oncology
Primary breast malignancies in adolescents and young adults: The MD Anderson Cancer Center experience.
2026 · Samanta Catueno, Adrian Gutierrez, et al. · Journal of Clinical Oncology
Phase I trial of combination gemcitabine (gem) and nab-sirolimus (nab-S) in advanced leiomyosarcomas (LMS) or advanced soft-tissue sarcomas (STS) with TSC1/2 alterations: Preliminary results.
2026 · Elise F. Nassif Haddad, Heather Y. Lin, et al. · Journal of Clinical Oncology
Safety and feasibility of cabozantinib (CABO) in combination with cisplatin, doxorubicin, and high-dose methotrexate (MAP) in patients with newly diagnosed high-risk osteosarcoma (OS).
2026 · Michael W. Bishop, Natalie J. DelRocco, et al. · Journal of Clinical Oncology
PDF
A phase 2 trial of cetuximab for patients with locally advanced/metastatic chordoma.
2026 · Anthony Paul Conley, J. Andrew Livingston, et al. · Journal of Clinical Oncology
An international framework for clinical translation of molecular classifiers in osteosarcoma
2026 · Amanda E. Marinoff, Michaela Nathrath, et al. · npj Precision Oncology
PDF
Potential biomarkers and preventative interventions for muscle wasting in adolescent and young adults with cancer: A translational study
2026 · Savannah V. Rauschendorfer, Fei Wang, et al. · Scientific Reports
PDF
Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone
2026 · Brina A. Patel, Jason T. Smith, et al. · Frontiers in Oncology
PDF
Works count: 32
Citation count: 2,632
H-index: 3
I10-index: 1
Year
Topic
Type